CLINICAL TRIAL / NCT05018286

Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.

  • Interventional
  • OPEN TO ACCRUAL
  • NCT05018286

An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.

The primary objective of the trial is to assess long-term safety and tolerability of apraglutide in subjects with SBS-IF.